JSPR - Jasper Therapeutics Inc
1.38
0.010 0.725%
Share volume: 1,174,074
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$1.37
0.01
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-13-2024 | 11-07-2024 | 02-28-2025 | 05-12-2025 | 11-10-2025 | |
| Cash flow financing | 47.349 M | 181.000 K | 9.000 K | 345.000 K | 0.000 | 28.388 M | |
| Other financing cash flows | 154.000 K | 136.000 K | 9.000 K | 30.000 K | 0.000 | 0.000 | |
| Cash flow | 31.588 M | -11.656 M | -14.317 M | -20.865 M | -22.838 M | 0.000 | |
| Net income | -13.728 M | -14.583 M | -18.637 M | -24.321 M | -21.241 M | -18.736 M | |
| Depreciation | 288.000 K | 299.000 K | 541.000 K | 245.000 K | 279.000 K | 229.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -25.000 K | -157.000 K | -274.000 K | -76.000 K | 4.000 K | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 25.000 K | 157.000 K | 274.000 K | 96.000 K | -4.000 K | 0.000 | |
| Cash Change | 31.588 M | -11.656 M | -14.317 M | -20.865 M | -22.838 M | 11.389 M |